BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23857397)

  • 1. Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?
    Senan S; Senthi S
    J Thorac Oncol; 2013 Aug; 8(8):995-6. PubMed ID: 23857397
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CyberKnife stereotactic ablative radiotherapy for lung tumors.
    Gibbs IC; Loo BW
    Technol Cancer Res Treat; 2010 Dec; 9(6):589-96. PubMed ID: 21070081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiotherapy versus sublobar lung resection in medically unfit patients with early-stage non-small-cell lung cancer.
    Jiwnani S; Karimundackal G; Pramesh CS
    J Clin Oncol; 2010 Oct; 28(29):e569-70; author reply e571-2. PubMed ID: 20660829
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD; Fernando HC
    Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stereotactic body radiation therapy for early non-small cell lung cancer].
    Zhang HQ; Li MH; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
    Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy for inoperable lung cancer.
    Rusthoven KE; Pugh TJ
    JAMA; 2010 Jun; 303(23):2354-5; author reply 2355. PubMed ID: 20551403
    [No Abstract]   [Full Text] [Related]  

  • 11. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer.
    Suppiah S; Linden P; Robke J; Schroeder C; Yao M; Machtay M; Lo SS
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1375-7. PubMed ID: 23249103
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of stereotactic ablative body radiation with targeted therapies.
    Zeng J; Baik C; Bhatia S; Mayr N; Rengan R
    Lancet Oncol; 2014 Sep; 15(10):e426-34. PubMed ID: 25186046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy.
    Palma DA; Senan S
    Clin Lung Cancer; 2013 Jan; 14(1):1-5. PubMed ID: 22846581
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.
    Oskan F
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stereotactic radiotherapy for early non-small cell lung cancer].
    Xing LG; Kong FM; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):641-4. PubMed ID: 23159074
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stereotactic ablative radiotherapy confirmed as a standard technique in NSCLC stage I].
    Hecht M; Fietkau R
    Strahlenther Onkol; 2019 Oct; 195(10):945-948. PubMed ID: 31410511
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracranial stereotactic body radiotherapy for stage I non-small cell lung cancer: still investigational or standard of care?
    Ball D
    J Thorac Oncol; 2008 Nov; 3(11):1209-10. PubMed ID: 18978553
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC.
    Allibhai Z; Cho BC; Taremi M; Atallah S; Hope A; Hwang D; Keshavjee S; Tsao M; Yasufuku K; Kim SW; Bezjak A
    Eur Respir J; 2012 Apr; 39(4):1039-42. PubMed ID: 22467727
    [No Abstract]   [Full Text] [Related]  

  • 20. SBRT effective for inoperable early-stage lung cancer.
    Cancer Discov; 2014 Dec; 4(12):OF2. PubMed ID: 25477119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.